The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost-utility analysis
Authors:
- Julio C. FurlanJFJulio C. Furlan
- Kelvin K.-W. ChanKCKelvin K.-W. Chan
- Guillermo A. SandovalGSGuillermo A. Sandoval
- Kenneth C. K. LamKLKenneth C. K. Lam
- Christopher A. KlingerCKChristopher A. Klinger
- Roy A. PatchellRPRoy A. Patchell
- Audrey LaporteALAudrey Laporte
- Michael G. FehlingsMichael G. Fehlings
Open Access
- 14 April 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 14 (5) , 631-640
Abstract
Neoplastic metastatic epidural spinal cord compression is a common complication of cancer that causes pain and progressive neurologic impairment. The previous standard treatment for this condition involved corticosteroids and radiotherapy (RT). Direct decompressive surgery with postoperative radiotherapy (S + RT) is now increasingly being chosen by clinicians to significantly improve patients’ ability to walk and reduce their need for opioid analgesics and corticosteroids. A cost-utility analysis was conducted to compare S + RT with RT alone based on the landmark randomized clinical trial by Patchell et al. (2005). It was performed from the perspective of the Ontario Ministry of Health and Long-Term Care. Ontario-based costs were adjusted to 2010 US dollars. S + RT is more costly but also more effective than corticosteroids and RT alone, with an incremental cost-effectiveness ratio of US$250 307 per quality-adjusted life year (QALY) gained. First order probabilistic sensitivity analysis revealed that the probability of S + RT being cost-effective is 18.11%. The cost-effectiveness acceptability curve showed that there is a 91.11% probability of S + RT being cost-effective over RT alone at a willingness-to-pay of US$1 683 000 per QALY. In practice, the results of our study indicate that, by adopting the S + RT strategy, there would still be a chance of 18.11% of not paying extra at a willingness-to-pay of US$50 000 per QALY. Those results are sensitive to the costs of hospice palliative care. Our results suggest that adopting a standard S + RT approach for patients with MSCC is likely to increase health care costs but would result in improved outcomes.Keywords
This publication has 20 references indexed in Scilit:
- Cost-effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compressionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- The World Health report 2006 1 : Working together for health 2Education for Health, 2006
- Systematic Review of the Diagnosis and Management of Malignant Extradural Spinal Cord Compression: The Cancer Care Ontario Practice Guidelines Initiative‘s Neuro-Oncology Disease Site GroupJournal of Clinical Oncology, 2005
- A Population-based Study of Malignant Spinal Cord Compression in OntarioClinical Oncology, 2003
- Primer on Medical Decision Analysis: Part 5—Working with Markov ProcessesMedical Decision Making, 1997
- Primer on Medical Decision Analysis: Part 2—Building a TreeMedical Decision Making, 1997
- Primer on Medical Decision Analysis: Part 3—Estimating Probabilities and UtilitiesMedical Decision Making, 1997
- Recommendations for Reporting Cost-effectiveness AnalysesJAMA, 1996
- Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and MedicineJAMA, 1996
- Spinal Cord Compression from Epidural MetastasesNew England Journal of Medicine, 1992